These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 1544266

  • 1. Scintigraphic evaluation with Tc-99m MDP and Ga-67 citrate in a case of pediatric T-cell lymphoma.
    Rivera-Rodriguez JE, Rodriguez AA, Turnbull GL, Moreno AJ.
    Clin Nucl Med; 1992 Jan; 17(1):61-4. PubMed ID: 1544266
    [No Abstract] [Full Text] [Related]

  • 2. Multifocal osteoarticular tuberculosis resembling skeletal metastatic disease. Evaluation with Tc-99m MDP and Ga-67 citrate.
    Hardoff R, Efrat M, Gips S.
    Clin Nucl Med; 1995 Mar; 20(3):279-81. PubMed ID: 7750230
    [No Abstract] [Full Text] [Related]

  • 3. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I, Friedman A, Sandler MP, Kedar A.
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [Abstract] [Full Text] [Related]

  • 4. Tc-99m-methylene diphosphonate (Tc-99 MDP) and Ga-67 concentration in soft tissue malignant fibrous histiocytoma (MFH): case report.
    Kida T, Hoshi K, Hoshino R, Fujita Y, Munakata S, Yanagisawa M.
    Ann Nucl Med; 1993 Feb; 7(1):57-60. PubMed ID: 8384870
    [Abstract] [Full Text] [Related]

  • 5. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
    Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G.
    J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
    [Abstract] [Full Text] [Related]

  • 6. Comparison of nuclear bone and gallium scans in the therapeutic evaluation of bone lymphoma.
    Moon TY, Kim EE, Kim YC, Chung JK, Kim BS, Lee SH, Kim KI, Podoloff DA.
    Clin Nucl Med; 1995 Aug; 20(8):721-4. PubMed ID: 7586878
    [Abstract] [Full Text] [Related]

  • 7. Scintigraphic "doughnut sign" on bone scintigraphy secondary to metastatic hepatocellular carcinoma.
    Hirano T, Otake H, Kanuma M, Mogi Y, Tatezawa T.
    Clin Nucl Med; 1995 Nov; 20(11):1020-1. PubMed ID: 8565359
    [No Abstract] [Full Text] [Related]

  • 8. Intense muscle uptake of Ga-67 citrate and Tc-99m MDP in a patient with aplastic anemia.
    Batte WG, Yeh SD, Rosenblum MK, Larson SM.
    Clin Nucl Med; 1991 Jun; 16(6):421-4. PubMed ID: 1868655
    [Abstract] [Full Text] [Related]

  • 9. Prognosis by nuclear medicine: can functional staging of cancer patients predict therapeutic response and survival?
    Haynie TP.
    J Nucl Med; 1993 Jul; 34(7):1087-9. PubMed ID: 8315483
    [No Abstract] [Full Text] [Related]

  • 10. Ga-67 citrate and Tc-99m MDP uptake in peritoneal metastases from a poorly differentiated adenocarcinoma of gynecologic origin.
    Bykov S, Garty I.
    Clin Nucl Med; 1997 May; 22(5):342-3. PubMed ID: 9152547
    [No Abstract] [Full Text] [Related]

  • 11. Intense muscle uptake of Tc-99m MDP and Ga-67 citrate in massive rhabdomyolysis.
    Provan I, Murray C, Mansberg VJ, Rossleigh MA.
    Clin Nucl Med; 1997 Jul; 22(7):463-6. PubMed ID: 9227868
    [Abstract] [Full Text] [Related]

  • 12. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
    Macdonald WB, Stevens MM, Dalla Pozza L, Bergin M, Menser MA, Howman-Giles R, Uren RF.
    J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous Tc-99m MDP and Ga-67 citrate uptake of benign lymphoid hyperplasia in the mastoid region.
    Sun SS, Tsai SC, Shiau YC, Kao CH.
    Clin Nucl Med; 2001 Sep; 26(9):797. PubMed ID: 11507308
    [No Abstract] [Full Text] [Related]

  • 14. Metastatic calcification. Difference of uptake between Tc-99m HMDP and Ga-67 citrate.
    Hirano T, Otake H, Ichikawa K, Ohmori Y, Kunitomo K.
    Clin Nucl Med; 1995 Sep; 20(9):849-50. PubMed ID: 8521674
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of 67 Ga citrate and 99m Tc bone scintigraphy at initial examination for primary oral squamous cell carcinoma.
    Onizawa K, Yoshida H.
    J Oral Maxillofac Surg; 2003 Aug; 61(8):913-7. PubMed ID: 12905444
    [Abstract] [Full Text] [Related]

  • 16. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
    Van de Wiele C, Dierckx RA, Simons M, Noens L.
    J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
    [No Abstract] [Full Text] [Related]

  • 17. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
    Simon MA, Kirchner PT.
    J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
    [Abstract] [Full Text] [Related]

  • 18. Renal cell carcinoma detection and systemic therapy with tumour-affine gallium-67 and with yttrium-90 citrate solutions.
    Shukla SK, Limouris GS, Cusumano R, Acconcia A, Cipriani C, Argiro G, Atzei G, Boemi S.
    Anticancer Res; 1997 Jul; 17(3B):1713-8. PubMed ID: 9179224
    [Abstract] [Full Text] [Related]

  • 19. Scintigraphic detection of osteomyelitis with Tc-99m MDP and Ga-67 citrate: concise communication.
    Graham GD, Lundy MM, Frederick RJ, Hartshorne MF, Berger DE.
    J Nucl Med; 1983 Nov; 24(11):1019-22. PubMed ID: 6226766
    [Abstract] [Full Text] [Related]

  • 20. The role of Tc-99m MDP and Ga-67 citrate in predicting the cure of osteomyelitis.
    Graham GD, Lundy MM, Moreno AJ, Frederick RJ.
    Clin Nucl Med; 1983 Aug; 8(8):344-6. PubMed ID: 6226468
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.